CIT GAP Funds Invests in OxiWear Device for PH Patients

CIT GAP Funds Invests in OxiWear Device for PH Patients

297493

CIT GAP Funds Invests in OxiWear Device for PH Patients

The Center for Innovative Technology (CIT) GAP Funds has invested in OxiWear and its ear-wearable device designed to continuously monitor blood oxygen levels in people with pulmonary hypertension (PH) and alert them when levels fall below safe thresholds. Oxiwear is expected to help patients get the help they need in due time, when dangerous drops of blood oxygen levels may occur unnoticed due to the absence of visible symptoms. That condition is called silent hypoxia…

You must be logged in to read/download the full post.